A case of primary non-small cell lung cancer with synchronous small cell lung cancer

  • Authors:
    • Hanli Wang
    • Zhiwei Lu
  • View Affiliations

  • Published online on: April 19, 2016     https://doi.org/10.3892/mco.2016.859
  • Pages: 171-174
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Synchronous multiple primary lung cancer is an uncommon and difficult to distinguish from metastatic disease. The present study reported an extremely rare case of a 66‑year‑old male with non‑small lung cell cancer in the left lobe and synchronous small cell lung cancer in the right lobe. The diagnosis of multiple primary lung cancer not only depends on biopsy pathology, but also requires molecular biology results. This is of great significance for the management and prognosis of multiple primary lung cancer. The management of patients with non‑small cell lung cancer-small cell lung cancer produces certain unique challenges, which may require individualized treatment modality that may not strictly comply with standard practices in the setting of a single tumor.
View Figures
View References

Related Articles

Journal Cover

July-2016
Volume 5 Issue 1

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang H and Wang H: A case of primary non-small cell lung cancer with synchronous small cell lung cancer. Mol Clin Oncol 5: 171-174, 2016
APA
Wang, H., & Wang, H. (2016). A case of primary non-small cell lung cancer with synchronous small cell lung cancer. Molecular and Clinical Oncology, 5, 171-174. https://doi.org/10.3892/mco.2016.859
MLA
Wang, H., Lu, Z."A case of primary non-small cell lung cancer with synchronous small cell lung cancer". Molecular and Clinical Oncology 5.1 (2016): 171-174.
Chicago
Wang, H., Lu, Z."A case of primary non-small cell lung cancer with synchronous small cell lung cancer". Molecular and Clinical Oncology 5, no. 1 (2016): 171-174. https://doi.org/10.3892/mco.2016.859